Design Therapeutics: Cash, Cash Equivalents & Marketable Securities as of June 30, 2024 Expected to Fund Its Planned Operating Expenses Into 2029
Design Therapeutics:截至2024年6月30日的現金、現金等價物和可變現證券預計可支持其計劃的營業費用直至2029年。
Design Therapeutics: Cash, Cash Equivalents & Marketable Securities as of June 30, 2024 Expected to Fund Its Planned Operating Expenses Into 2029
Design Therapeutics:截至2024年6月30日的現金、現金等價物和可變現證券預計可支持其計劃的營業費用直至2029年。
譯文內容由第三人軟體翻譯。